Why the study?
CMR has emerged as a mainstream technique providing unique information for clinical decision-making, necessitating an updated consensus statement on its current state of technology and clinical applications.
This position paper provides updated appropriate use criteria for cardiovascular magnetic resonance imaging across various cardiac conditions.
Guides appropriate CMR use across IHD, CHD, cardio-oncology, masses, and transplants; extends prior consensus with updated technology and applications.
Cardiac magnetic resonance (CMR) has emerged as new mainstream technique for the evaluation of patients with cardiac diseases, providing unique information to support clinical decision-making. This document has been developed by a joined group of experts of the Italian Society of Cardiology and Italian society of Radiology and aims to produce an updated consensus statement about the current state of technology and clinical applications of CMR. The writing committee consisted of members and experts of both societies who worked jointly to develop a more integrated approach in the field of cardiac radiology. Part 1 of the document will cover ischemic heart disease, congenital heart disease, cardio-oncology, cardiac masses and heart transplant.
No takes yet. Share an insight, caveat, or question.
Pontone et al. (2021) conducted a review in Cardiovascular diseases (ischemic, congenital, cardio-oncology, cardiac masses, heart transplant). Cardiovascular magnetic resonance imaging (CMR) was evaluated. Cardiovascular magnetic resonance imaging provides unique information to support clinical decision-making and is recommended for the evaluation of ischemic heart disease, congenital heart disease, cardio-oncology, cardiac masses, and heart transplant.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: